| Lisa A Zittergruen, MD | |
|
901 Montgomery St, Decorah, IA 52101-2325 | |
| (563) 382-2911 | |
| (563) 382-4143 |
| Full Name | Lisa A Zittergruen |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 901 Montgomery St, Decorah, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043446149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD-39307 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Winneshiek Medical Center Hospice | Decorah, IA | Hospice |
| Winneshiek Medical Center | Decorah, IA | Hospital |
| Aase Haugen Home | Decorah, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Winneshiek Medical Center | 4688582935 | 74 |
| Winneshiek Medical Center | 4688582935 | 74 |
News Archive
In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists, including Professor Seth Love at Bristol University, slammed the government's underinvestment in dementia research amid warnings of "catastrophic" economic consequences.
The team, based at the Neuroscience and Psychiatry Unit (NPU), in the Faculty of Medical and Human Sciences, has set up a website (www.newmood.co.uk) where would-be volunteers can see how prone they may be to depression by identifying the emotions on people's faces and taking a gambling test.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian.
› Verified 8 days ago
| Entity Name | Winneshiek Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992854863 PECOS PAC ID: 4688582935 Enrollment ID: O20040316001437 |
News Archive
In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists, including Professor Seth Love at Bristol University, slammed the government's underinvestment in dementia research amid warnings of "catastrophic" economic consequences.
The team, based at the Neuroscience and Psychiatry Unit (NPU), in the Faculty of Medical and Human Sciences, has set up a website (www.newmood.co.uk) where would-be volunteers can see how prone they may be to depression by identifying the emotions on people's faces and taking a gambling test.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian.
› Verified 8 days ago
| Entity Name | Winneshiek Medical Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1619922051 PECOS PAC ID: 4688582935 Enrollment ID: O20061104000215 |
News Archive
In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists, including Professor Seth Love at Bristol University, slammed the government's underinvestment in dementia research amid warnings of "catastrophic" economic consequences.
The team, based at the Neuroscience and Psychiatry Unit (NPU), in the Faculty of Medical and Human Sciences, has set up a website (www.newmood.co.uk) where would-be volunteers can see how prone they may be to depression by identifying the emotions on people's faces and taking a gambling test.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa A Zittergruen, MD 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911 | Lisa A Zittergruen, MD 901 Montgomery St, Decorah, IA 52101-2325 Ph: (563) 382-2911 |
News Archive
In an open letter to the Health Secretary Alan Johnson, a coalition of leading scientists, including Professor Seth Love at Bristol University, slammed the government's underinvestment in dementia research amid warnings of "catastrophic" economic consequences.
The team, based at the Neuroscience and Psychiatry Unit (NPU), in the Faculty of Medical and Human Sciences, has set up a website (www.newmood.co.uk) where would-be volunteers can see how prone they may be to depression by identifying the emotions on people's faces and taking a gambling test.
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).
Hospitalized COVID-19 patients at a New York City medical facility had higher rates of kidney complications than other COVID-19 patient groups in different areas of the U.S. and other countries, according to a new study from researchers at Columbia University Irving Medical Center and NewYork-Presbyterian.
› Verified 8 days ago
Eric William Svestka, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 | |
Paul G Wenner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery Street, Winneshiek Medical Center, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-387-3102 | |
Kent William Svestka, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 | |
Bill R Withers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1830 State Highway 9, Decorah, IA 52101 Phone: 563-382-3140 | |
Kevin L Sand, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-9671 Fax: 563-382-5015 | |
Kurt A Swanson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1830 State Highway 9, Decorah, IA 52101 Phone: 563-382-3140 |